texto impreso

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair

Salazar, C.A. ; Malaga, G. ; Malasquez, G. ; Bernardo, R. | Cochrane Collaboration | 2019-02-22T14:56:09Z

This is the protocol for a review and there is no abstract. The objectives are as follows: To examine the existing clinical evidence on the efficacy of prophylactic anticoagulation with direct factor Xa inhibitors versus low molecular weight hep[...]

Más información...

Añadir a la cesta

Ningún comentario para este registro.

En línea: